Job openings snapped back in August and rose to 9.6 million, reflecting a robust appetite for labor in light of a steadily growing U.S. economy.
: Kevin McCarthy vote today: Speakership appears in peril as House lets Matt Gaetz’s motion go forward
The House votes Tuesday against killing a measure that would remove Speaker Kevin McCarthy from his post, setting the stage for a vote on it later in the day.
Market Extra: ‘Just like in 1987.’ Here’s what could deliver a ‘devastating blow’ to stocks, says SocGen strategist Albert Edwards.
Société Générale’s sharp-tongued strategist Albert Edwards is warning of a 1987-style event for stock markets if the bond market does not cool off.
Europe Markets: Boohoo and Burberry shares slide amid tough times for British fashion brands
British fashion brands were under pressure Tuesday, amid anxiety over a faltering U.K. consumer and slowing global growth for luxury labels.
: ‘Taylor Swift: The Eras Tour’ sets pre-sales records for Cinemark
The “Taylor Swift The Eras Tour” concert film hits theaters Oct. 13.
: U.K. bakery chain reports surge in sales
Greggs on Tuesday said its sales have increased by more than 20% over the past three months, thanks to cost-conscious customers.
Brett Arends’s ROI: Few who ‘retire early’ have achieved ‘financial independence’
Of those who take early retirement, just 17% do so of their own free choice, with enough money.
The Ratings Game: Tesla’s stock falls, as a long-time bear sees the falling profit outlook as a bigger problem than weak deliveries
Tesla’s stock fell Tuesday after J.P. Morgan’s Ryan Brinkman affirmed his long-time bearish call after the EV maker missed deliveries expectations.
The Ratings Game: Airbnb’s stock slumps after KeyBanc downgrade on expectations the leisure travel recovery is sagging
KeyBanc downgraded Airbnb Inc.’s stock and said leisure travel is expected to pull back after a strong recovery from the peak pandemic years.
: Medicare drug price negotiations move forward with all drugmakers participating, White House says
Novo Nordisk is latest drugmaker to challenge negotiation program in court.
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 1275
- Next Page »